Biomarker Analysis Service (Simoa)

Izmir Biomedicine and Genome Center (IBG) provides high-sensitivity biomarker quantification services through the Quanterix SR-X platform, offering access to Simoa (Single Molecule Array) technology for research applications.

Simoa enables up to a 1000-fold increase in analytical sensitivity compared with conventional immunoassay methods, allowing reliable quantification of low-abundance proteins that were previously below detection limits. This capability provides a significant technical advantage for studies focused on early-stage neurodegeneration, neuroinflammation, and related biological processes.

The analysis panels are currently available:

• NfL/GFAP Panel: Designed for the high-sensitivity measurement of biomarkers associated with neuronal injury, axonal integrity, and glial activation.
• Alzheimer Panel: Supports the quantification of key Alzheimer-related biomarkers, including Total Tau, Aβ42, and Aβ40.

This service infrastructure is accessible to academic and industrial researchers conducting studies in neuroscience, biomarker discovery, clinical research, and translational medicine.

For information on incorporating this technology into your project and to discuss potential collaboration opportunities, please contact.

Contact: burcu.ekinci@ibg.edu.tr